Patient and parent preferences for immunoglobulin treatments: a conjoint analysis

References

• Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency disease in the United States. J Clin Immunol 2007;27:497–502
   PubMed Web of Science ®Google Scholar
• Immune Deficiency Foundation (IDF). Diagnostic & clinical care guidelines for primary immunodeficiency diseases. 2009. http://primaryimmune.org/wp-content/uploads/2011/04/IDF-Diagnostic-Clinical-Care-Guidelines-for-Primary-Immunodeficiency-Diseases-2nd-Edition.pdf. Accessed June 29, 2012
   Google Scholar
• Lindegren ML, Kobrynski L, Rasmussen SA, et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep 2004;53:1-29
   PubMedGoogle Scholar
• Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameters for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005;94:s1-s61
   Web of Science ®Google Scholar
• Savides C, Shaker M. More than just infections: an update on primary immune deficiencies. Curr Opin Pediatr 2010;22:647-54
   PubMedGoogle Scholar
• Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006;117(4 Suppl):S525-53
   PubMed Web of Science ®Google Scholar
• Siegel J. The product: all intravenous immunoglobulins are not equivalent. Pharmacotherapy 2005;25:78S-84S
   PubMed Web of Science ®Google Scholar
• Gelfand EW. Differences between IGIV products: impact on clinical outcome. Int Immunopharmacol 2006;6:592-9
   PubMed Web of Science ®Google Scholar
• Bonilla FA. IgG replacement therapy, no size fits all. J Clin Immunol 2011;2:107-9
   Google Scholar
• Fasth A, Nyström J. Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin. J Clin Immunol 2008;28:370-8
   PubMed Web of Science ®Google Scholar
• Crawford B, Dalal AA, Stanford R, et al. Validation of the Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS-Q): a patient reported outcomes (PRO) questionnaire to measure experience and preference with nasal sprays. J Allergy Clin Immunol 2008;121(2 Suppl 1):S106
   Google Scholar
• Bridges J, Jones C. Patient based health technology assessment: a vision of what might one day be possible. Int J Technol Assess Health Care 2007;23:30-5
   PubMed Web of Science ®Google Scholar
• Bridges JFP, Kinter ET, Kidane L, et al. Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982-2007. Patient 2008;1:273-82
   PubMedGoogle Scholar
• Mohamed AF, Epstein JD, Li-McLeod JM. Patient and parent preferences for haemophilia A treatments. Haemophilia 2011;17:209-14
   PubMed Web of Science ®Google Scholar
• Mohamed AF, Hauber AB, Neary MP. Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma. Pharmacoeconomics 2011;29:977-88
   PubMed Web of Science ®Google Scholar
• Johnson FR, Özdemir S, Mansfield C, et al. Crohn’s disease patients’ risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology 2007;133:769-77
   PubMed Web of Science ®Google Scholar
• Johnson FR, Hauber AB, Özdemir S, et al. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn’s disease management. J Manag Care Pharm 2010;16:616-28
   PubMed Web of Science ®Google Scholar
• Hauber AB, Mohamed AF, Johnson FR, et al. Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications. Allergy Asthma Proc 2009;30:139-47
   PubMed Web of Science ®Google Scholar
• Hauber AB, Mohamed AF, Watson ME, et al. Benefits, risks, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments. AIDS Patient Care STDs 2009;23:29-34
   PubMed Web of Science ®Google Scholar
• Bridges JFP, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 2011;14:403-11
   PubMed Web of Science ®Google Scholar
• Kuhfeld W. Marketing research methods in SAS: experimental design, choice, conjoint, and graphical techniques. Cary, NC: SAS Institute Inc, 2010
   Google Scholar
• Kuhfeld W, Tobias F, Garratt M. Efficient experimental design with marketing research applications. J Mark Res 1994;31:545-57
   Web of Science ®Google Scholar
• Train K. Discrete choice methods with simulation. Cambridge: CUP, 2003. p 138-54
   Google Scholar
• Train K, Sonnier G. Mixed logit with bounded distributions of correlated partworths. In: Scarpa R, Alberini A, ed. Applications of simulation methods in environmental and resource economics. Dordrecht: Springer Publisher, 2005. p 117-34
   Google Scholar
• Hensher DA, Rose JM, Greene WH. Applied choice analysis. Cambridge: CUP, 2005
   Google Scholar
• Louviere JJ, Hensher DA, Rose JM, et al. Stated choice methods: analysis and applications. Cambridge: CUP, 2000
   Google Scholar
• Bech M, Gyrd-Hansen D. Effects coding in discrete choice experiments. Health Econ 2005;14:1079-83
   PubMed Web of Science ®Google Scholar
• American Pharmacists Association/APhA. Medication Compliance-Adherence Persistence (CAP) Digest. Washington, DC: American Pharmacists Association and Pfizer Pharmaceuticals, 2003. www.nhtsa.gov/people/injury/olddrive/druguse. Accessed March 29, 2012
   Google Scholar
• Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25:2958-71
   PubMed Web of Science ®Google Scholar
• Dragomir A, Cote R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010;48:418-25
   PubMed Web of Science ®Google Scholar
• Gwadry-Sridhar FH, Manias E, Zhang Y, et al. A framework for planning and critiquing medication compliance and persistence research using prospective study designs. Clin Ther 2009;31:421-35
   PubMed Web of Science ®Google Scholar
• Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004;27:2149-53
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
   PubMed Web of Science ®Google Scholar
• Sheth K, Derebery J, Mahr T, et al. Ineffective control of allergic rhinitis symptoms reduces patient satisfaction and adherence with treatment. J Allergy Clin Immunol 2008;121:S106
   Google Scholar
• Kittner, J, Grimbacher B, Wulff W, et al. Patients’ attitude to subcutaneous immunoglobulin substitution as home therapy. J Clin Immunol 2006;26:400-5
   PubMed Web of Science ®Google Scholar